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ABSTRACT
Background: Despite the recent introduction of a number 
of technical and pharmacologic blood conservation measures, 
bleeding and allogeneic transfusion remain persistent prob-
lems in open-heart surgical procedures. Efforts should be 
made to decrease or completely avoid transfusions to avoid 
these negative reactions.
Methods: Our coronary artery bypass grafting database 
was reviewed retrospectively and a total of 243 patients who 
underwent cardiac surgery with cardiopulmonary bypass 
(CPB) were studied in a 12-month period (January-December 
2016) after the implementation of the new program, and com-
pared with 275 patients of the previous 12-month period.
All the staff involved in the care of the patients were edu-
cated about the risks and benefits of blood transfusions and 
the new transfusion guidelines in a 45-min training. We 
revised our guidelines for transfusions based on the STS. A 
transfusion log was created. Reduction in IV fluid volume 
was targeted. CPB circuitry was redesigned to achieve signifi-
cantly less prime volume. 
Results: The proportion of patients transfused with 
red blood cells was 56% (n =154) in the control group and 
reduced by 26.8% in the study group (29.2%; 71 patients; 
P < .01). Blood transfusion rate (1.7 ± 1/3.05 ± 1 units), post-
operative hemorrhage (545 ± 50/ 775 ± 55 mL), respiratory 
support duration (12.4 ± 7/16.8 ± 8 h) and ICU stay (2.2±1.1/ 
3.5±1.2 days) were significantly better in the blood conserva-
tion group.  
Conclusion: These findings, in addition to risks and side 
effects of blood transfusion and the rising cost of safer blood 
products, justify blood conservation in adult cardiac operations. 
INTRODUCTION
Despite the recent introduction of a number of techni-
cal and pharmacologic blood conservation measures, bleed-
ing and allogeneic transfusion remain persistent problems in 
open-heart surgical procedures. The use of blood products 
carries several risks, such as immunologic sensitization, ana-
phylactic reaction, and disease transmission. The underlying 
pathophysiology has not been described entirely; however, 
there is evidence on the activation of inflammatory genes 
and cytokines in circulating leukocytes with transfusion of 
red blood cells [Escobar 2007]. Efforts should be made to 
decrease or completely avoid transfusions to avoid these 
negative reactions.
In an effort to reduce the negative impact of CPB on 
the adult population outcome, the minimized systems were 
developed to significantly reduce the hemodilution of the 
patient and reduce the foreign surface area that comes in con-
tinuous contact with the patient circulating blood volume. 
Reducing the size of the perfusion apparatus has two obvious 
and immediate effects: first, a reduction in the contact surface 
area for potential blood-biomaterial contact; and second, a 
reduction in priming volume requirement-less hemodilution 
with a consequential reduction in perioperative hematocrit 
[Gunaydin 2009].
There is wide variation in the prevalence of perioperative 
transfusions in cardiac surgery. A 2013 audit of cardiac surgi-
cal units in the United Kingdom identified a threefold varia-
tion (22-67%) in the number of patients receiving at least 
one unit of blood perioperatively [Murphy 2013]. Variation 
in blood usage and the need to balance risks and benefits have 
encouraged the use of pragmatic and evidence-based strate-
gies to optimize blood component administration.
The large differences between institutions cannot be 
explained just by differences in patient characteristics. Most 
likely, institutional and individual differences in transfusion 
practice, guidelines, and attitudes influence the frequency and 
number of transfusions. The decision to transfuse is based 
on multiple patient factors and it is impossible to designate 
a single transfusion trigger. The high prevalence initiated a 
multifactorial blood conservation program with the intention 
of reducing transfusions without compromising patient safety 
[Arnold 2006].
The World Health Organization encourages all member 
states to implement Patient Blood Management programs 
employing multiple combined strategies to increase and pre-
serve autologous erythrocyte volume in order to minimize 
unnecessary exposure to RBC transfusions [Farmer 2013].
The aim of this retrospective study was to evaluate the 
efficacy of a structured program to reduce transfusions and 
transfusion-associated complications in adult cardiac surgery. 
PATIENTS AND METHODS
After institutional review board approval (14/227-2) in a 
tertiary cardiac center, the coronary artery bypass grafting 
(CABG) database was reviewed retrospectively and a total of 
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243 patients who underwent cardiac surgery with cardiopul-
monary bypass (CPB) (Group 1: blood conservation) were 
studied in a 12-month period (January-December 2016) after 
the implementation of the new program, and compared with 
275 patients (Group 2: control−no blood conservation) of the 
previous 12-month period.
The outcome (dependent-variable) was stated as blood 
transfusion. Independent variables were identified. 
Exclusion criteria consisted of known coagulopathy and 
endocarditis. Patients on anti-platelet therapy preoperatively 
received the same protocol. The remainder of the patients who 
did not have the exclusion criteria were included in the study.
The blood conservation program was designed as follows:
Education: All the staff involved in the care of the patients, 
including surgeons, anesthetists, residents, OR-, ICU- and 
ward nurses, nurse helpers, physiotherapists and perfusionists 
were educated about the risks and benefits of blood trans-
fusions and the new transfusion guidelines in a 45-minute 
lesson. The lesson was repeated for all new employees. 
Guidelines: We revised our guidelines for transfusions 
based on the Society of Thoracic Surgeons Guidelines [Senay 
2009]. In the institutional guidelines, the decision to transfuse 
red cells perioperatively should be based on clinical judgment 
of the patient’s clinical and hemodynamic status. Generally, 
patients were supposed to receive red blood cells if they had 
a hematocrit level of <20%, mixed venous oxygen saturation 
<60% and regional cerebral oxygenation (rSO2) <50%. The 
final decision to transfuse or not was always at the discretion 
of the physician responsible.
Transfusion log: A specific transfusion log was added 
to the patient records. In this log, all transfusion episodes 
were registered together with time of transfusion, indication 
for transfusion, type of blood product, amount (units), and 
patient status including blood pressure, pulse, mixed venous 
oxygenation, hematocrit levels and the prescribing physician. 
Reduction in IV fluid volume: We initiated a series 
of measures aimed at reducing hemodilution volume. All 
sources and volumes of IV fluid were obtained from the 
medical record.      
CPB circuit design: significantly less prime volume via 
oxygenator with integrated arterial filter, condensed circuit, 
pole mounted vents, microplegia, ultrafiltration, use of cere-
bral oxymetry-rSO2, retrograde autologous priming, vacuum 
assisted venous drainage, and cell salvage of the residual blood 
from the circuit without treatment.
Operative Technique 
As a part of the blood conservation program, the bypass 
circuit was aseptically assembled using a low-prime integrated 
oxygenator and reservoir (Fx15, Terumo Medical Corpora-
tion, Ann Arbor, MI, USA) in Group 1 and a Terumo System 
1 pump console. All of the roller heads of the pump were 
remotely mounted to minimize tubing length and circuit sur-
face area. Isothermic blood cardioplegia was administered 
directly into the aorta at the surgical field using premixed 
syringes of a 1:4 hyperkalemic solution (1 part blood: 4 parts 
crystalloid) (Pharmedium, Portland, OR, USA). The static 
prime volume for the circuit was approximately 250 mL. 
As part of our previous routine, the control group consisted 
of a conventional oxygenator and reservoir (Sorin, Arvada, 
CO, USA) that has a static priming volume of 450 mL.
Anticoagulation status was monitored using the Medtronic 
HMS+ (Medtronic, Minneapolis, MN, USA) system. Sam-
ples of blood for measuring activated clotting times (ACT) 
and heparin concentrations were drawn every 30 minutes on 
CPB. Adequate anticoagulation was defined as ACT greater 
than 500 seconds and heparin concentration assays greater 
than or equal to 3.0 mg/kg, as measured by the HMS+ device. 
Midazolam, sevoflurane, fentanyl, and norcuronium were 
used as anesthetic agents.
After median sternotomy, the patient was systemically 
anticoagulated using 339 units/kg of intravenous heparin. 
The pulse pressure was verified and retrograde autologous 
priming (RAP) was initiated. 
Table 1. Preoperative Characteristics of the Patients 
Blood Management Control
Group 1 (n = 243) Group 2 (n = 275) P
Age 69.4 ± 10 66.1 ± 10 >.05 
Sex (male) 117 126 >.05 
BSA (m2) 1.69 ± 0.05 1.73 ± 0.05 >.05 
Preop EF (%) 0.45 ± 0.08 0.48 ± 0.08 >.05 
EuroSCORE 6.6 ± 2.3 6.9 ± 1.5 >.05 
Anti-platelet therapy, n 195 204 >.05 
CADX1 17 14 >.05 
CADX2 64 73 >.05 
CADX3 69 79 >.05 
CADx4+ 93 109 .036
BSA indicates body surface area; EF, ejection fraction detected by echocar-
diography; CAD, coronary artery disease.
Table 2. Significant Predictors of Alllogeneic Transfusions
Risk Factors Odds Ratio Confidence Interval Multivariate P
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Vacuum-assisted venous drainage was utilized to allow 
for the use of the smaller venous cannula and venous circuit. 
Upon initiation of bypass, crystalloid in the venous line was 
diverted into a collection bag and discarded. Full flow to the 
patient was achieved with no hemodynamic instability within 
five minutes of aortic cannulation. 
CPB flow was maintained at 125-150 mL/kg/minute. 
Moderate hypothermia (28-34°C) and alpha stat blood gas 
management were used.
After the surgical procedure, the heart was aggressively de-
aired. The aortic cross-clamp was removed and the patient 
was systemically rewarmed to normothermia. A second blood 
gas was drawn to ensure proper electrolyte balance prior to 
termination of CPB support. The resultant hematocrit was 
around 20%. Continuous ultrafiltration was performed while 
the patient was on CPB. Circuit integrity was maintained 
until the patient was transported to the pediatric intensive 
care unit.
Perioperative Follow-up
For each patient, the following factors were evaluated 
before discharge and documented:
Hemodynamic parameters, perfusion and cross-clamp 
duration, intubation period, postoperative hemorrhage, use 
of blood (as units) during the hospital stay, use of inotropic 
support, complications and infection, the duration of ICU 
stay and hospital stay, perioperative mortality. A comparison 
between groups was performed retrospectively. 
Blood Samples and Assays
Complete blood count (hemoglobin, hematocrit, eryth-
rocyte, white blood cell [WBC] and platelet counts) was 
recorded. Results of standard blood and urine chemistry 
were documented. 
Statistical Analysis 
Data was expressed as the mean ± standard error of the 
mean. Analysis of variance for comparison of parameters 
with normal distribution, and Mann Whitney U test for 
comparison of parameters without normal distribution were 
used. Univariate analysis was performed on a large number of 
preoperative and intraoperative variables in our database to 
identify those variables that might be associated with alloge-
neic blood. They were entered into a stepwise multiple logis-
tic regression analysis to select the ones that were significant 
independent predictors of the need for transfusion. Data were 
analyzed using SPSS program.
RESULTS
Preoperative evaluation of groups is summarized in Table 1. 
The two groups were generally comparable preoperatively. 
Preoperative physical and laboratory evaluation revealed 
no difference between patient groups. A list of variables 
that were screened for possible association with transfusion 
(dependent variable: transfused allogeneic blood) and signifi-
cant predictors of allogeneic transfusions are listed in Table 2. 
The proportion of patients transfused with red blood cells 
was 56% (n = 154) in the control group and reduced by 26.8% 
in the study group (29.2%; 71 patients; P < .01).
Perioperative outcome is listed in Table 3.  
DISCUSSION
Our main motive for organizing a structured patient blood 
management program was to document that the proportion 
of patients transfused with red blood cells was 56%. This was 
not acceptable. All staff (surgeon, anesthesiologists, nurses, 
and perfusionists) remained the same. Our target was to 
diminish transfusion without compromising patient safety. 
We published several CPB-related blood preservation 
studies before and demonstrated the positive impact of each 
strategy separately [Gourlay 2008; Gunaydin 2011; McCusker 
2006; Senay 2009]. In this project, we implemented what-
ever we thought we could benefit from. Our main prospect 
was to employ novel CPB techniques that would result in 
less hemodilution. 
CPB-related technologies for targeting blood preservation 
were all confirmed on an evidence-based level in recent guide-
lines [Ferraris 2011]: Condensed CPB circuit as Class I-A; 
microplegia as Class IIb-B; vacuum-assisted venous drainage 
as Class IIb-C; retrograde autologous priming as Class IIb-B 
and ultrafiltration as Class IIa.  A multi-disciplinary blood 
conservation program was also cited as Class IIa evidence. 
One of the greatest benefits of the low prime condensed 
circuits is in the reduction of CPB prime by eliminating an 
external arterial line filter and the associated filter bypass 
loop and extra tubing needed to encompass the use of an arte-
rial line filter. The elimination of an external arterial filter 
has not only reduced the overall CPB surface area but has 
also allowed us to decrease our overall prime volumes. This 
has been accomplished through a reduction in static prime 
volume and also by allowing placement of the oxygenator 
closer to the patient. 
In our series, for the blood conservation group, the pro-
portion of patients transfused with red blood cells was 56% 
(n = 154) in the control group and reduced by 26.8% in the 
Table 3. Perioperative Outcome
Blood Conservation Control
Group 1 Group 2 P
Duration of CPB, min 90.4 ± 46 92 ± 42 .98
Duration of x-clamp, min 54.4 ± 16 62.2 ± 17 .94
t-intub, h 12.4 ± 7* 16.8 ± 8 .044
Postop hemorrhage, mL 545 ± 50* 775 ± 55 .046
Blood transfusion, unit 1.7 ± 1* 3.05 ± 1 .015
Inotropic support, n 75(37.8%)* 115 (56%) .017
ICU stay, day 2.2 ± 1.1* 3.5 ± 1.2 .045
Hospital stay, day 6.4 ± 3 7.5 ± 4 .065
Mortality, n − 2 .24
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study group (29.2%; 71 patients, P < .01). Blood transfusion 
rate (1.7 ± 1/3.05 ± 1 units), postoperative hemorrhage (545 ± 
50/ 775 ± 55 mL), respiratory support duration (12.4 ± 7/16.8 
± 8 h), and ICU stay (2.2 ± 1.1/ 3.5 ± 1.2 days) were signifi-
cantly better in the blood conservation group.  
We studied thorough variables related to the preoperative 
and intraoperative period and demonstrated that the most 
significant risk factors for transfusion were body surface area 
(OR: 2.16), preoperative hematocrit (OR: 2.3), red blood cell 
mass (OR: 1.1), total crystalloid volume (OR: 3.6), conven-
tional circuit (OR: 3.1), and postoperative bleeding in 24 h 
(OR: 4.7). The results of the present study demonstrate that 
a structured blood conservation program reduces transfusion 
prevalence and this can be achieved without compromising 
patient safety.
Several public-based blood management initiatives are in 
progress to optimize utilization of RBC concentrates [Menkis 
2012]. However, none of these initiatives are designed to 
provide scientific data in terms of safety issues. Thus, a large 
study with robust and relevant clinical endpoints is required. 
The objective of this study is to demonstrate that the imple-
mentation of a patient blood management program is safe 
and achievable.
Our study is a retrospective study and this is one of the 
main limitations of the design. We accept this data as pre-
liminary to build a strategy and started a newer protocol and 
assessment based on current outcomes obtained from ret-
rospective evaluation and long-term clinical outcome. We 
accept that using historic data as a control group in such a 
comparative study has less power. But we made every effort 
to match both databases to make a comparison as much as 
is logical. 
In order to continue to improve surgical outcomes, we 
must continue to ask the correct questions and attempt to 
answer them with the appropriate studies. Our patient popu-
lation is small. That may be a reason not to get clear signifi-
cant differences in most of the clinical parameters. 
Our results confirm that transfusion of red blood cells during 
CPB may cause an undesirable clinical outcome. It is obvious 
that blood management with multiple strategies is valid for 
an adult population. Hemodilution becomes more important 
in lower body surface area. We believe novel CPB technolo-
gies may positively contribute to blood management strategies 
regarding adult patients undergoing open-heart surgery.
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